A phone app to help people with speech problems from a brain tumor
Official title: Listen Aphasia Pilot Study
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on .
The short version
This study is testing a phone app made to help people talk when a brain tumor has made speech hard.
Read our full plain-language summary
What the trial team says
This is a feasibility and pilot study to refine and test LISTEN, an AI-based augmentative and alternative communication (AAC) smartphone app, integrated into the patient's personal electronic device, to augment and facilitate communication in patients with tumor-related aphasia (TRA) and their care partners. The study will assess the feasibility and acceptability of LISTEN in patients with TRA and their care partners.
Key facts
- Registry number
- NCT07732140
- Stage of testing
- Not applicable
- Conditions studied
- Aphasia, Malignant Brain Tumor
Where it is running
This trial lists 2 sites.
-
Massachusetts
- Brigham & Woman's Hospital (Boston)
- Dana-Farber Cancer Center (Boston)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.